An interventional study of Health Information Literacy Enhancement in Metabolic Syndrome (MetS), sponsored by Meihua Ji. Enrolling by invitation at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-05.
Sponsored by Meihua Ji · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 89 studies in Metabolic Syndrome with a site in China — 35 open to participants now, 39 under way, 1 of them phase 3. Metabolic Syndrome · China.
Among the 89 studies in Metabolic Syndrome with a site in China, this one is the 48th largest by planned enrollment of the 50 interventional ones that give a count, is one of 11 that started in 2025, is one of 39 with no phase, reaches primary completion later than 5 of the 38 other live ones, and was the 67th registered.
2,120 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.
Browse Metabolic Syndrome studies →35 of the 89 studies in Metabolic Syndrome with a site in China are open now. Recruiting first, the newest first:
First Affiliated Hospital of Chongqing Medical University · Sites in China
Ages 18–65
Zhujiang Hospital · Sites in China
Ages 18–60
Liu Yan · Sites in China
Ages 18–65
Hudson Biotech · Sites in China
Ages 18–65
Meihua Ji · Sites in China
Ages 18–75
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
89 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 6 · Phase 4 4
First in 2000; this study’s year is marked. 11 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 60 across 1,574 interventional studies indexed under Metabolic Syndrome.
Median enrollment 143 across the 50 interventional studies, 1,249 across the 39 observational. Of the 39 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 89 have an industry lead sponsor. The 10 most frequent:
Meihua Ji is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Meihua Ji has 2 studies filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
12 of the studies in Metabolic Syndrome with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05105321Tang YidaCardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) | 2026-12 |
| NCT07096102Meihua JiEfficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome | 2026-12-30 |
| NCT07327684Peking Union Medical College HospitalPhotoacoustic/Ultrasound Imaging of Brown Adipose Tissue Activity | 2026-12-31 |
| NCT07822763First Affiliated Hospital of Chongqing Medical UniversityPreoperative Oral Carbohydrate Loading and Gastrointestinal Recovery After Bariatric Surgery in Metabolic Syndrome | 2027-01 |
| NCT07505745Hudson BiotechMOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity | 2027-02-14 |
Add all 12 to your calendar (.ics) → With an account.
Among the 89 studies in Metabolic Syndrome with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the preliminary effect of a health-information literacy promotion program for individuals with Metabolic Syndrome (including its subtypes) based on the Health Empowerment Theory. The study aims to answer the following questions:
Does the intervention improve health information literacy among study participants? Does the intervention lead to better health outcomes, including weight, waist circumference, BMI control, and metabolic health indicators (blood pressure, blood glucose, glycated hemoglobin, and blood lipids)?
Participants will:
Undergo the intervention program for 6 weeks (face to face and online) and will be assessed regularly to monitor changes in their health information literacy and health outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A 6-week intervention programme was implemented for the health information literacy enhancement group, once a week, with each intervention lasting 30-40min, to enable the study participants to actively practice healthy behaviours through intervention techniques such as health awareness awakening, social resource building, and health-related skill empowerment, in order to enhance the health information literacy of the study participants, and ultimately to enable the study participants to perceive health in a programmatic manner.
Behavioral: Health Information Literacy Enhancement
Participants will undertake a six-week programme to enhance their health information literacy. The specific details are as follows: 1. Capacity Building on Health Information Management via Health Education Based on the Health Empowerment Theory: ① Strengthening skills related to Health Information Literacy; ② Training on Medication Management Skills; ③ Practice of Self-Monitoring Skills; ④ Education on Diet and Exercise Management Knowledge. 2. Health Behavior Motivation Management Based on the Health Empowerment Theory: ① Personalized Goal Setting; ② Behavioral Incentives and Feedback; ③ Construction of Peer Support Networks; ④ Demonstration Effect of Role Models. 3. Health Management Support System Based on the Health Empowerment Theory: ① Online Dynamic Monitoring; ② Family-Community Collaborative Support; ③ Digital Monitoring Platform; ④ Continuous Supply of Resources.
Health Information Literacy
Health information literacy (HIL) is essential to assist individuals in health decision-making. In this study, health information literacy will be measured using the Health Information Literacy Self-rating Scale.A 5-point Likert scale was used, with scores ranging from 1-5 for 'strongly disagree' to 'strongly agree', and a total scale score ranging from 29-145, with higher scores indicating higher levels of health information literacy. In the original study, the Cronbach's α coefficient for HILSS was 0.847, and the Cronbach's α coefficients for the dimensions.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks).
Health Literacy
Health literacy refers to an individual's ability to obtain, process, and understand basic health information and services, and to make appropriate health decisions. Compared with health information literacy, the concept and scope of health literacy are more general and broader. In this study, the Newest Vital Sign scale will be used to assess individuals' overall health literacy levels.The measure has six questions assessing a person's reading, numeracy, and comprehension based on an ice cream nutritional label.1 point for each correct answer, 6 questions in total, total score 0-6 points, the higher the score the higher the health literacy. The internal consistency (Cronbach's α) was 0.76.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks).
Chronic Patient Self-Management Questionnaire
The Self-Management Questionnaire for Chronic Patients used to assess the self-management level of patients with chronic diseases. The scale includes five aspects: dietary habits, exercise management, medication adherence, emotional management, and family and social support, and adopts the Likert 5-point rating method. The questionnaire consists of 20 multiple choice questions with a total score of 100 points. The scoring criteria are: between 20 and 60 points is a poor level of self-management; between 60 and 80 points is a medium level of management; between 80 and 100 points is a high level of self-management. The Cronbach's α coefficient of the scale is 0.957.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks)
Health Problem-Solving
The Chinese version of the Health Problem-Solving Scale consists of 6 dimensions: rational/effective problem-solving, positive positive transfer problem-solving, avoidance problem-solving, impulsive/careless problem-solving, negative transfer/learning, and negative motivation/attitude. It includes 30 items. The Likert 5-point scoring method was used, with the lowest score being 0 and the highest score being 4. The higher the score, the better the health problem solving ability. The content validity index of the scale is 0.970, the content validity index of the items ranges from 0.830 to 1.000, the Cronbach's α coefficient is 0.911, and the Cronbach's α coefficients of each dimension range from 0.715 to 0.839.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks)
Chronic Illness Resources
The Chronic Illness Resource Survey (CIRS) consists of 19 items measuring six aspects of social resources: individuals, family and friends, healthcare team, community, media policy and community organisations. The scale is scored on a 5-point Likert scale, ranging from 1 to 5. Higher scores indicate greater access to or use of resources. The scale had good reliability in the original study, with a Cronbach's α coefficient of 0.820, and an overall Cronbach's α coefficient of 0.845 in the Chinese population.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks)
Health-related Quality of Life
A health-related quality of life scale, the EQ-5D-5L, developed by the EuroQol Group, will be used to measure individuals' quality of life. It comprises the EQ-5D descriptive system and the EQ-5D Visual Analog Scale (EQ VAS). The five dimensions assess participants' mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension having five levels: no difficulties, slight difficulties, moderate difficulties, severe difficulties, and extreme difficulties/unable to perform. the UI scores ranged from -0.391 to 1.The EQ VAS records a participant's self-assessed health status on a vertical visual analogue scale labelled 'Your best imagined health (100 points)' and 'Your worst imagined health (0 points)'. The EQ VAS provides a quantitative description of the respondent's perception of their overall health. Higher scores indicate higher quality of life. EQ-5D-5L has been validated by Chinese scholars with a Cronbach coefficient of 0.624.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks)
Nutrition Literacy
The Food and Nutrition Literacy Questionnaire, developed by the School of Public Health at Peking University, will be used for assessment. The current status of nutrition literacy includes four dimensions: knowledge and concepts related to food, selecting food, preparing food, and consuming food. The questionnaire has a score of 100 points, and the critical value of this questionnaire is 80 points, and a score of 80 points or more represents nutritional literacy, and the proportion of patients with nutritional literacy is the level of nutritional literacy. The Cronbach'sacoefficient of the scale is 0.893, and the content validity is 0.891, which is considered to be good.
Time frame: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started May 2025 (actual). Primary completion is estimated for Sep 2025, 4 months after the start.
Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's planned 4 months is below that.
Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.